Literature DB >> 2610511

Mechanism of La Crosse virus inhibition by ribavirin.

L F Cassidy1, J L Patterson.   

Abstract

The effect of ribavirin on the growth and replication of La Crosse virus was examined. The data suggest that low concentrations of ribavirin have a marked effect on the initial steps of La Crosse virus transcription. The therapeutic potential of ribavirin in the treatment of human California encephalitis serotype infections is discussed in light of these findings.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2610511      PMCID： PMC172805          DOI： 10.1128/AAC.33.11.2009

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

1.  ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.

Authors:  W H THOMPSON; B KALFAYAN; R O ANSLOW
Journal:  Am J Epidemiol       Date:  1965-03       Impact factor: 4.897

2.  Plus and minus strand leader RNAs in negative strand virus-infected cells.

Authors:  M Leppert; L Rittenhouse; J Perrault; D F Summers; D Kolakofsky
Journal:  Cell       Date:  1979-11       Impact factor: 41.582

3.  The translational requirement for La Crosse virus S-mRNA synthesis.

Authors:  D Kolakofsky; C Bellocq; R Raju
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1987

4.  LaCrosse virus gene expression in mammalian and mosquito cells.

Authors:  C Rossier; R Raju; D Kolakofsky
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

5.  The use of thin acrylamide gels for DNA sequencing.

Authors:  F Sanger; A R Coulson
Journal:  FEBS Lett       Date:  1978-03-01       Impact factor: 4.124

6.  Molecular analysis of the inhibitory effect of phosphorylated ribavirin on the vesicular stomatitis virus in vitro polymerase reaction.

Authors:  R Fernandez-Larsson; K O'Connell; E Koumans; J L Patterson
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

7.  Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.

Authors:  R W Sidwell; J H Huffman; G P Khare; L B Allen; J T Witkowski; R K Robins
Journal:  Science       Date:  1972-08-25       Impact factor: 47.728

8.  Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.

Authors:  D G Streeter; J T Witkowski; G P Khare; R W Sidwell; R J Bauer; R K Robins; L N Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1973-04       Impact factor: 11.205

9.  Structural proteins of La Crosse virus.

Authors:  J F Obijeski; D H Bishop; F A Murphy; E L Palmer
Journal:  J Virol       Date:  1976-09       Impact factor: 5.103
View more
  14 in total

1.  Mechanism of action of ribavirin in the treatment of chronic hepatitis C.

Authors:  Helen S Te; Glenn Randall; Donald M Jensen
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-03

Review 2.  Antiviral therapy: current concepts and practices.

Authors:  B Bean
Journal:  Clin Microbiol Rev       Date:  1992-04       Impact factor: 26.132

3.  Mutagen resistance and mutation restriction of St. Louis encephalitis virus.

Authors:  Sara B Griesemer; Laura D Kramer; Greta A Van Slyke; Janice D Pata; David W Gohara; Craig E Cameron; Alexander T Ciota
Journal:  J Gen Virol       Date:  2017-02       Impact factor: 3.891

4.  Inhibitory effect of a nucleotide analog on infectious salmon anemia virus infection.

Authors:  Andrea Rivas-Aravena; Eva Vallejos-Vidal; Marcelo Cortez-San Martin; Felipe Reyes-Lopez; Mario Tello; Patricia Mora; Ana María Sandino; Eugenio Spencer
Journal:  J Virol       Date:  2011-06-08       Impact factor: 5.103

5.  Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.

Authors:  W Markland; T J McQuaid; J Jain; A D Kwong
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

6.  Rottlerin inhibits La Crosse virus-induced encephalitis in mice and blocks release of replicating virus from the Golgi body in neurons.

Authors:  Durbadal Ojha; Clayton W Winkler; Jacqueline M Leung; Tyson A Woods; Catherine Z Chen; Vinod Nair; Katherine Taylor; Charles D Yeh; Gregory J Tawa; Charles L Larson; Wei Zheng; Cathryn L Haigh; Karin E Peterson
Journal:  Nat Microbiol       Date:  2021-10-21       Impact factor: 17.745

7.  Tensaw virus genome sequence and its relation to other Bunyaviridae.

Authors:  Stacey L Watts; Alejandra Garcia-Maruniak; James E Maruniak
Journal:  Virus Genes       Date:  2009-09-17       Impact factor: 2.332

8.  Neuroprotection and reduced proliferation of microglia in ribavirin-treated bornavirus-infected rats.

Authors:  Marylou V Solbrig; Robert Schlaberg; Thomas Briese; Nigel Horscroft; W Ian Lipkin
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

9.  Ribavirin causes error catastrophe during Hantaan virus replication.

Authors:  William E Severson; Connie S Schmaljohn; Ali Javadian; Colleen B Jonsson
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 10.  Encephalitic Arboviruses: Emergence, Clinical Presentation, and Neuropathogenesis.

Authors:  Hamid Salimi; Matthew D Cain; Robyn S Klein
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.